Similar Search Results

Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia : a Markov model parameterized using administrative data

Frey, Simon; Linder, Roland; Juckel, Georg; Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 15 (2014) 2, pp. 133-142

Persistent link: https://www.econbiz.de/10010254965

Health-economic evaluation of home telemonitoring for COPD in Germany : evidence from a large population-based cohort

Achelrod, Dmitrij; Schreyögg, Jonas; Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 18 (2017) 7, pp. 869-882

Persistent link: https://www.econbiz.de/10011869110

Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data

Frey, Simon; Linder, Roland; Juckel, Georg; Stargardt, Tom - In: The European Journal of Health Economics 15 (2014) 2, pp. 133-142

We use longitudinal patient-level data from a German sickness fund with 7.26 million insured in a Markov-simulation model to assess the cost-effectiveness of long-acting injectable risperidone (LAI-RIS) compared with long-acting injectable flupentixol (LAI-FLX) in the long-term management of...

Persistent link: https://www.econbiz.de/10010993904

Cost-effectiveness of open versus laparoscopic appendectomy: a multilevel approach with propensity score matching

Haas, Laura; Stargardt, Tom; Schreyoegg, Jonas - In: The European Journal of Health Economics 13 (2012) 5, pp. 549-560

Predicted costs for LA were 1,856 US$ lower than for OA while the postoperative complication rate did not differ significantly. Thus, LA is the treatment of choice from a provider’s perspective. </AbstractSection> Copyright Springer-Verlag 2012

Persistent link: https://www.econbiz.de/10010993925

A framework to evaluate the effects of small area variations in healthcare infrastructure on diagnostics and patient outcomes of rare diseases based on administrative data

Stargardt, Tom; Schreyögg, Jonas - In: Health Policy 105 (2012) 2, pp. 110-118

Small area variations in healthcare infrastructure may result in differences in early detection and outcomes for patients with rare diseases.

Persistent link: https://www.econbiz.de/10011048412